Document is current

Article History

Accepted: 29 May 2022

First Online: 7 June 2022

Declarations

:

: The authors have no conflicts of interest to declare that are relevant to the content of this article.

: The MTN-032/Assessment of ASPIRE and HOPE Adherence (AHA) study was designed and implemented by the Microbicide Trials Network (MTN). The MTN is funded by the National Institute of Allergy and Infectious Diseases (UM1AI068633, UM1AI068615, UM1AI106707), with co-funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Institute of Mental Health, all components of the United States (US) National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The vaginal rings used in this study were supplied by the International Partnership for Microbicides (IPM).

: The MTN 032 study protocol was approved by the Institutional Review Boards at RTI International, and at each study site and regulated by the U.S. National Institutes of Health and the Microbicide Trials Network.

: Informed consent was obtained from all individual participants included in the study.

: All participants were informed that any publication of this study will not use their name or identify them personal.